Trichomonas vaginalis
Kryptos Biotechnologies Gets $1.2M Grant From RIGHT Foundation for Rapid STI Test
The funding will support optimization of a PCR-based test system and development of a 30-minute test to detect chlamydia, gonorrhea, and trichomoniasis.
Aptitude Medical Systems Gets Gates Foundation Grant for At-Home STI Test
The funding will support development of a point-of-care and over-the-counter molecular diagnostic to detect chlamydia, gonorrhea, and trichomonas.
Visby Medical Point-of-Care STI Test Gets FDA 510(k) Clearance, CLIA Waiver
The PCR test detects sexually transmitted infections caused by Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis in women.
Becton Dickinson High-Throughput MDx Module, Triplex STI Test Get FDA 510(k)Clearance
Along with a sample prep module, the BD Cor MX module is capable of delivering as many as 1,000 sample results in 24 hours.
BD Gets CE Mark, Australian Regulatory Approval for New Cor MX Instrument
The new MX instrument, which is based on the firm's BD Max PCR instrument, is the final component of the high-throughput BD Cor system.
Sep 2, 2021
Jan 31, 2020
NeuMoDx T. Vaginalis, M. Genitalium Assay CE Marked
May 29, 2019
FDA Clears Two Hologic Vaginitis Assays
Mar 6, 2018
Qiagen Trichomonas Assay Gets CE Mark
Sep 3, 2014
Cepheid Trichomoniasis Test Gets CE-IVD Mark
Jan 14, 2013
Hologic Gets FDA Clearance for Trichomonas Assay
Feb 16, 2012
Apr 20, 2011
FDA Clears Gen-Probe's Trichomonas Assay
Oct 5, 2010